Between us, we have over 40 years of experience in nanomedicine research. Over these years, we have been consistently disappointed with how bad PB/PK is for nanoparticles.
As we started to learn more about PB/PK, we realised this wasn't just isolated to nanomedicine. PB/PK is a major stumbling block in the drug development pipeline, and we know we can do something about it.
Scroll
CEO
Joe wrote his PhD thesis on modelling viral endocytosis. He has worked at startups in fintech, insurance, and sports, in roles spanning business analyst, principal engineer, and head of development. He co-founded Informed Kinetics to apply the skills he developed to a sector where the outcomes really matter.
CTO
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
CSO
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Scroll
Informed Kinetics operates as a contract research organisation. Our scientists run every model and validate every result.
We work directly with your team — scoping the problem, building the model, interpreting the results. No self-serve dashboard, no black box.
Every output is reviewed by experienced nanomedicine and PB/PK researchers before it reaches you. You get answers we would stake our name on.
Every engagement is run under strict confidentiality. Your molecules, your results, and the deliverables we build for you stay between us — never shared with another client or disclosed beyond the project.
Scroll
